RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis

Yongsheng Huang1,2, Sijia Liu3, Mengjie Shan4

  • 1Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. yongsheng@ibms.pumc.edu.

Cell Death & Disease
|January 11, 2022
PubMed

Insights

High RNF12 expression promotes breast cancer metastasis by enhancing TGF-β signaling via AKT. RNF12 overexpression correlates with poor prognosis and invasiveness in breast cancer patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-β (TGF-β) is a key driver of metastasis in advanced breast cancer.
  • RNF12, an E3 ubiquitin ligase, enhances TGF-β signaling by degrading SMAD7, but its regulation and role in cancer remain unclear.

Purpose of the Study:

  • To investigate the role of RNF12 in breast cancer progression and its regulation by AKT signaling.
  • To elucidate the mechanistic link between RNF12, AKT, and TGF-β pathways in breast cancer metastasis.

Main Methods:

  • Analysis of RNF12 expression in human breast cancer tissues and correlation with prognosis.
  • In vitro studies using breast cancer cell lines to assess migration, invasion, and metastasis.
  • Zebrafish and murine xenograft models for experimental metastasis.
  • Western blotting and immunofluorescence to determine protein levels, localization, and interactions.

Main Results:

  • RNF12 is overexpressed in invasive breast cancers, correlating with poor prognosis.
  • High RNF12 expression promotes breast cancer cell migration, invasion, and metastasis in vivo.
  • AKT-mediated phosphorylation of RNF12 enhances its stability, nuclear localization, and SMAD7 degradation.
  • RNF12 and AKT signaling pathways cooperate in promoting breast cancer cell migration.
  • RNF12 expression correlates with phosphorylated AKT and SMAD2 in patient tissues.

Conclusions:

  • RNF12 is a critical mediator of breast cancer progression and metastasis.
  • The AKT-mediated regulation of RNF12 highlights a crucial crosstalk between AKT and TGF-β signaling.
  • RNF12 represents a potential therapeutic target for aggressive breast cancer subtypes.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.8K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.9K